1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Neuland Laboratories Limited
  6. Company
    524558   INE794A01010

NEULAND LABORATORIES LIMITED

(524558)
  Report
End-of-day quote Bombay Stock Exchange  -  05-19
1026.75 INR   +0.27%
05/11Neuland Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2022
CI
05/10Neuland Laboratories Limited Recommends Payment of Final Dividend
CI
05/10Neuland Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Neuland Laboratories Limited is a manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs. The company is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. The Company operates through manufacture of active pharmaceutical ingredients and allied services. The Company has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its products and services include Levetiracetam, Mirtazapine, Ciprofloxacin, Enalapril, Sotalol, Labetalol and Custom Manufacturing Services. The Company’s capabilities include FBRM, research and development, peptide laboratory, poly block reactors, laboratory reactors, heating and cooling systems, hazardous and wet laboratory, PID Laboratory Unit-III, PID Laboratory B-S Unit-I, and other lab equipment. The Company has 3 manufacturing facilities and one R&D facility in Hyderabad.

Number of employees : 2 425 people.
Sales per Business
20202021Delta
Active Pharmaceutical Ingredients7 089.8593%8 812.5294.1% +24.3%
Services254.673.3%369.243.9% +44.99%
Export Incentives204.452.7%126.481.3% -38.14%
Scrap49.630.7%35.540.4% -28.39%
Impurities28.520.4%25.350.3% -11.11%
INR in Million
Sales per region
20202021Delta
Europe2 400.4732.7%3 301.8336% +37.55%
India2 278.3831%2 181.4123.8% -4.26%
United States1 145.2915.6%1 941.2321.1% +69.5%
Rest of the World1 520.3720.7%1 757.2919.1% +15.58%
INR in Million
Managers
Name Title Age Since
Davuluri Sucheth Rao Vice Chairman & Chief Executive Officer 46 2015
Deepak Gupta Chief Financial Officer - 2020
Sarada Bhamidipati Secretary & Compliance Officer - 2012
Davuluri Saharsh Rao Vice Chairman & Managing Director 42 2020
Members of the board
Name Title Age Since
Davuluri Rama Mohan Rao, Dr. Executive Chairman & Joint Managing Director 77 1984
Humayun Raja Dhanrajgir Independent Non-Executive Director 85 1994
Parampally Vasudeva Maiya Independent Non-Executive Director 83 1999
Bharati Manohar Rao Independent Non-Executive Director 72 2014
Nirmala Murthy, Dr. Independent Non-Executive Director 75 2015
Homi Rustum Khusrokhan Independent Non-Executive Director 78 2019
Davuluri Sucheth Rao Vice Chairman & Chief Executive Officer 46 2015
Cristopher Michael Cimarusti, Dr. Non-Executive Director 78 2009
Davuluri Saharsh Rao Vice Chairman & Managing Director 42 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 12,900,500 9,257,532 71.8% 0 0.0% 71.8%
Shareholders
NameEquities%
Davuluri Rama Mohan Rao 3,203,474 25.0%
Malabar Investments LLC 1,832,238 14.3%
Davuluri Vijaya Rao 613,338 4.78%
Matthews International Capital Management LLC 473,363 3.69%
Davuluri Sucheth Rao 337,542 2.63%
Mukul Mahavir Agrawal 300,000 2.34%
Davuluri Saharsh Rao 253,487 1.98%
Ocean Dial Asset Management Ltd. 234,000 1.82%
Davuluri Rohini Niveditha Rao 163,414 1.27%
Dolly Khanna 161,336 1.26%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Neuland Laboratories Limited
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
NEULAND LABORATORIES LIMITED-33.68%169
JOHNSON & JOHNSON1.68%465 705
PFIZER, INC.-11.14%294 404
ELI LILLY AND COMPANY8.19%269 013
ABBVIE INC.11.53%266 851
ROCHE HOLDING AG-15.67%266 707
NOVO NORDISK A/S3.58%245 099
MERCK & CO., INC.22.06%236 570
ASTRAZENECA PLC20.93%202 681
NOVARTIS AG8.00%193 025
BRISTOL-MYERS SQUIBB COMPANY22.20%162 213
SANOFI15.49%134 759
AMGEN INC.10.01%132 214
GLAXOSMITHKLINE PLC9.80%111 286
BAYER AG35.62%66 062
DAIICHI SANKYO CO., LTD.13.20%49 636
CHUGAI PHARMACEUTICAL CO., LTD-5.33%45 478
TAKEDA PHARMACEUTICAL COMPANY LIMITED18.87%45 016
JIANGSU HENGRUI MEDICINE CO., LTD.-40.37%28 822
ASTELLAS PHARMA INC.4.92%27 643
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-30.05%27 566